Status:
COMPLETED
Measurement of the Second Gas Effect on Sevoflurane in Anaesthetised Patients
Lead Sponsor:
Austin Health
Conditions:
Anesthesia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is investigating the "second gas effect", a phenomenon produced by the uptake of nitrous oxide (N2O) by the lungs, during the course of a typical anaesthetic. The effect is to increase the ...
Detailed Description
This study is investigating the "second gas effect", a phenomenon produced by the uptake of nitrous oxide (N2O) by the lungs, during the course of a typical anaesthetic. The effect is to increase the ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients scheduled for elective surgery requiring relaxant general anaesthesia with arterial blood pressure monitoring via an arterial line.
- Exclusion criteria:
- Patients with moderately or severely impaired respiratory disease (FEV1 \< 1.5L, or FVC \< 2.0L).
- Patients under 18 years of age.
- Morbidly obese patients: BMI \> 30
- Patients unable to give informed consent.
Exclusion
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00321191
Start Date
May 1 2006
End Date
September 1 2006
Last Update
June 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Austin Hospital
Melbourne, Victoria, Australia, 3084